The obesity rate in the US is over 40% according to a recent study by the Centers for Disease Control and Prevention, and it is the highest among working age adults, making this public health crisis one that requires employers to be involved in the solution. Obesity leads to over 200 co-morbidities, giving it a causal connection to expensive health plan cost drivers such as type 2 diabetes, cancer, heart disease and stroke.
Science has debunked the stigma of obesity being a personal failing of the individual, similar to its disproving that substance abuse could be overcome by just saying “no”. Obesity is perhaps the only chronic disease not widely covered by major health plans, yet the current array of treatment options are highly valued by employees and an opportunity for both recruitment and retention.
What options do employers have in covering GLP-1s? Should they consider the “too good to be true” costs promised by compounders? What is the impact of going the direct-to-consumer route with pharmaceutical companies? What options do employers have when offering coverage? Attend this session find out.
تعرّف على مقدمي العروض
لقد وافقت شهادة SHRM على هذه الندوة عبر الإنترنت للحصول على شهادة PDC واحدة من أجل إعادة اعتمادSHRM أو SHRM. سيتم توفير رمز البرنامج في نهاية الندوة عبر الإنترنت.